[HTML][HTML] Safety and efficacy of bivalirudin with glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention
NV Deshpande, R Pratiti, P Admane, D Mukherjee… - Indian heart …, 2012 - Elsevier
Aims The aim of the study was to assess the safety and efficacy of Bivalirudin+ Glycoprotein
(Gp) IIb/IIIa inhibitor as compared to unfractionated Heparin (UFH)+ Gp IIb/IIIa inhibitor in …
(Gp) IIb/IIIa inhibitor as compared to unfractionated Heparin (UFH)+ Gp IIb/IIIa inhibitor in …
Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: a meta-analysis of randomized clinical trials
OBJECTIVE: This meta-analysis was performed to assess the efficacy and safety of
bivalirudin compared with unfractionated heparin or enoxaparin plus glycoprotein (GP) …
bivalirudin compared with unfractionated heparin or enoxaparin plus glycoprotein (GP) …
Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?
S Doggrell - Expert Opinion on Pharmacotherapy, 2003 - Taylor & Francis
The combined use of low dose heparin and glycoprotein (GP) IIb/IIIa blockers is standard
treatment during percutaneous coronary interventions (PCIs). Bivalirudin has a different …
treatment during percutaneous coronary interventions (PCIs). Bivalirudin has a different …
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
DN Feldman, SC Wong, G Bergman… - The Journal of invasive …, 2009 - europepmc.org
Objectives This study sought to evaluate the frequency and efficacy of combination of
bivalirudin and provisional glycoprotein (GP) IIb/IIIa blockade compared with bivalirudin …
bivalirudin and provisional glycoprotein (GP) IIb/IIIa blockade compared with bivalirudin …
Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study
B Cortese, A Micheli, A Picchi, L Bandinelli… - Coronary Artery …, 2009 - journals.lww.com
Objective Bivalirudin, a direct thrombin inhibitor, provides similar ischemic outcomes with
significantly less major bleeding compared with unfractionated heparin (UFH) plus a …
significantly less major bleeding compared with unfractionated heparin (UFH) plus a …
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary …
Objectives: The purpose of this study was to compare the cost of percutaneous coronary
intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa …
intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa …
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention …
AM Lincoff, JA Bittl, RA Harrington, F Feit, NS Kleiman… - Jama, 2003 - jamanetwork.com
ContextThe direct thrombin inhibitor bivalirudin has been associated with better efficacy and
less bleeding than heparin during coronary balloon angioplasty but has not been widely …
less bleeding than heparin during coronary balloon angioplasty but has not been widely …
[PDF][PDF] Comparisons of effectiveness and safety between bivalirudin and heparin with tirofiban in ST-segment elevation myocardial infarction treated with percutaneous …
P He, H Wei, M Wulasihan, Y Yang, Z Liu, Y Ma… - Int J Clin Exp …, 2016 - e-century.us
Objective: To compare the effectiveness and safety between bivalirudin and heparin with
tirofiban in patients with acute myocardial infarction by percutaneous coronary intervention …
tirofiban in patients with acute myocardial infarction by percutaneous coronary intervention …
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary …
AM Lincoff, NS Kleiman, DJ Kereiakes, F Feit, JA Bittl… - Jama, 2004 - jamanetwork.com
ContextIn the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events
(REPLACE)-2 trial, bivalirudin with provisional glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibition was …
(REPLACE)-2 trial, bivalirudin with provisional glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibition was …
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous …
JE Exaire, SM Butman, R Ebrahimi, NS Kleiman… - American heart …, 2006 - Elsevier
BACKGROUND: The REPLACE-2 trial demonstrated the noninferiority of bivalirudin with
provisional glycoprotein IIb/IIIa (GPIIb/IIIa) blockade as compared with heparin plus planned …
provisional glycoprotein IIb/IIIa (GPIIb/IIIa) blockade as compared with heparin plus planned …